Insurance of the Costs of Pharmaceuticals in the Netherlands: A Law and Economics Perspective
Posted: 5 Jan 2003 Last revised: 16 Jun 2010
In this paper Faure and Philipsen address price regulation and insurance for pharmaceuticals in the Netherlands. The authors first analyse, qualitatively, the complex regulatory framework and insurance for pharmaceuticals. After that, they examine the various actors in the drug distribution market, with a specific focus on pharmacists (as their income is influenced by the insurance mechanism). The findings of this paper are relevant to other areas and other countries as well. After all, a central question is how the regulatory and insurance frameworks affect the optimal allocation of resources with respect to the financing of pharmaceuticals.
Keywords: Health Insurance, Netherlands, Price Regulation, Pharmaceuticals, Public Choice.
JEL Classification: K23, K32
Suggested Citation: Suggested Citation